Skip to main content
. 2025 Oct 24;176(1):42. doi: 10.1007/s11060-025-05299-0

Table 2.

Frequency of pathogenic genomic alterations in the tumor at diagnosis

Genomic Alteration No. Present (%) No. Absent (%) No. Not tested (%)
MGMT promoter methylation 51 (29.1) 123 (70.3) 1 (0.6)
TERT variant 55 (31.4) 24 (13.7) 96 (54.9)
EGFR amplification 38 (21.7) 52 (29.7) 85 (48.6)
TP53 variant 33 (18.9) 45 (25.7) 97 (55.4)
PTEN variant 22 (12.6) 57 (32.6) 96 (54.8)
EGFR variant 20 (11.4) 70 (40.0) 85 (48.6)
PIK3CA variant 10 (5.7) 74 (42.3) 91 (52.0)